VivoSim Labs, Inc. Deferred Tax Assets, Operating Loss Carryforwards
VivoSim Labs, Inc. (VIVS) had Deferred Tax Assets, Operating Loss Carryforwards of $0 as of 2022-03-31, per its 10-K filed 2022-06-10.
Discontinued › Notes › Deferred Tax Assets, Gross › Deferred Tax Assets, Operating Loss Carryforwards, Components
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2022-06-10
- 2022-03-31: Deferred Tax Assets, Operating Loss Carryforwards $0.00.
- 2021-03-31: Deferred Tax Assets, Operating Loss Carryforwards $0.00.
- 2020-03-31: Deferred Tax Assets, Operating Loss Carryforwards $0.00.
- 2019-03-31: Deferred Tax Assets, Operating Loss Carryforwards $0.00.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards |
|---|---|
| 2022-03-31 | $0.00 10-K · filed 2022-06-10 |
| 2021-03-31 | $0.00 10-K · filed 2022-06-10 |
| 2020-03-31 | $0.00 10-K · filed 2021-06-15 |
| 2019-03-31 | $0.00 10-K · filed 2020-05-28 |
| 2018-03-31 | $0.00 10-K · filed 2019-06-03 |
| 2017-03-31 | $0.00 10-K · filed 2018-05-31 |
| 2016-03-31 | $0.00 10-K · filed 2018-05-31 |
| 2015-03-31 | $0.00 10-K · filed 2016-06-09 |
| 2014-03-31 | $0.00 10-K · filed 2015-06-09 |
| 2011-12-31 | $1.62M 10-KT · filed 2013-05-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |